Literature DB >> 21303874

Development and validation of a quantitative assay based on tandem mass spectrometry.

John W Honour1.   

Abstract

Many routine hospital and clinical research assays have relied upon immunoassay procedures to achieve sensitive measurements of a range of important analytes. Some of the methods have been developed in-house but increasingly commercial kits and automated analysers have become commonplace. The accuracies of these methods are under question in health care. Mass spectrometry (MS) is potentially a more accurate technique with the ability to demonstrate specificity. An introduction of the basic analytical aspects of liquid chromatography (LC)-MS/MS leads on to the validation of the method before general use. LC coupled with MS and tandem mass spectrometry (MS(n)) is being adopted in a number of hospital laboratories for the quantitative analysis of a number of analytes from physiological matrices, but standards for development and validation of such assays are not easily available. Most assays can be regarded as in-house methods and herein may lay the failure so far for mass spectrometric methods to improve quality of results between laboratories for an analyte using the same technology. Manufacturers are taking on board the experience of clinical laboratories with kits containing all or most of the disposable items and reagents. A number of documents and guidelines have been consulted. These documents are expensive to purchase, are often very long and not easy to read. This review highlights the specific requirements for introduction of a tandem mass spectrometric test for small molecules into a routine hospital laboratory. A number of experiments need to be planned and executed in order to describe a new quantitative method in terms of selectivity, accuracy, imprecision, sensitivity and stability. The introduction of a quantitative method based on tandem MS requires careful validation. This review has distilled out important points from a number of key documents in order to provide a working validation guideline for clinical laboratories. In a supplementary file a working document for assembling the assay validation is proposed.

Mesh:

Year:  2011        PMID: 21303874     DOI: 10.1258/acb.2010.010176

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  17 in total

1.  A New Approach for Fast Metabolic Diagnostics in CMAMMA.

Authors:  Monique G M de Sain-van der Velden; Maria van der Ham; Judith J Jans; Gepke Visser; Hubertus C M T Prinsen; Nanda M Verhoeven-Duif; Koen L I van Gassen; Peter M van Hasselt
Journal:  JIMD Rep       Date:  2016-02-27

Review 2.  Fat-Soluble Vitamins: Clinical Indications and Current Challenges for Chromatographic Measurement.

Authors:  Ali A Albahrani; Ronda F Greaves
Journal:  Clin Biochem Rev       Date:  2016-02

3.  A guide to harmonisation and standardisation of measurands determined by liquid chromatography - tandem mass spectrometry in routine clinical biochemistry.

Authors:  Ronda F Greaves
Journal:  Clin Biochem Rev       Date:  2012-11

Review 4.  The use of mass spectrometry to improve the diagnosis and the management of the HPA axis.

Authors:  Phillip J Monaghan; Brian G Keevil; Peter J Trainer
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

5.  Laboratory medicine best practice guideline: vitamins a, e and the carotenoids in blood.

Authors:  Ronda F Greaves; Gerald A Woollard; Kirsten E Hoad; Trevor A Walmsley; Lambro A Johnson; Scott Briscoe; Sabrina Koetsier; Tamantha Harrower; Janice P Gill
Journal:  Clin Biochem Rev       Date:  2014-05

Review 6.  Clinical Features of Psoriatic Arthritis: a Comprehensive Review of Unmet Clinical Needs.

Authors:  Angela McArdle; Stephen Pennington; Oliver FitzGerald
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

7.  Validation of a dual LC-HRMS platform for clinical metabolic diagnosis in serum, bridging quantitative analysis and untargeted metabolomics.

Authors:  Ilya Gertsman; Jon A Gangoiti; Bruce A Barshop
Journal:  Metabolomics       Date:  2014-04-04       Impact factor: 4.290

Review 8.  Achievements and Future Directions of the APFCB Mass Spectrometry Harmonisation Project on Serum Testosterone.

Authors:  Ronda F Greaves; Chung S Ho; Kirsten E Hoad; John Joseph; Brett McWhinney; Janice P Gill; Therese Koal; Chris Fouracre; Heidi P Iu; Brian R Cooke; Conchita Boyder; Hai T Pham; Lisa M Jolly
Journal:  Clin Biochem Rev       Date:  2016-05

9.  Method development and validation for analysis of phenylalanine, 4-hydroxyphenyllactic acid and 4-hydroxyphenylpyruvic acid in serum and urine.

Authors:  Andrew T Hughes; Anna M Milan; Ella Shweihdi; James Gallagher; Lakshminarayan Ranganath
Journal:  JIMD Rep       Date:  2022-04-03

10.  A Pilot Study of the Normative Range of Overnight Urinary Free Cortisol Corrected for Creatinine in Children.

Authors:  Ole D Wolthers; Sabine Mersmann; Sanjeeva Dissanayake
Journal:  Clin Drug Investig       Date:  2018-04       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.